TrialStroke2017

MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial.

Andrew Bivard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.